6 min. Read

That weird FDA de-regulatory notice.

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health. Thanks to everyone who sent over names of digital health startups that spun out of pharmaceutical companies. (I received a lot of emails.) Working on a round-up of those for next week, so hit reply if you think I might be missing any.

 E&O Fridays.

OK, here's what's happening this week in the world of pharma digital products and FDA-regulated digital health:

  • The big hire this week goes to Amalgam Rx, which just announced that the COO of CMS, Jennifer Main, will join the company next month as its COO and CFO.
  • Meanwhile, investment dollars continue to flow: Happify Health announced a sizeable $73 million Series D led by Deerfield Management Company.
  • The big product launch this week goes to AstraZeneca, which officially 

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Spring Health’s new biz. Coca-Cola’s benefits.
8 min. Read
Facebook’s RCT for AI bot Zenny. More trials
7 min. Read
Which virtual clinics got FTC-OCR letters?
6 min. Read
Digging into the Omada-Amazon marketing deal.
9 min. Read
FDA de novo for Google smartphone thermometer.
6 min. Read
New state launches for Midi Health, HeyJane, Swing Care and more
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
8 min. Read
Teladoc customer wins. Pricing database updates
5 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
6 min. Read
UnitedHealth’s employee benefits. Omada signals IPO. Detailed Spring Health pricing.
9 min. Read
  • First
  • Previous
  • 1 of 35
  • Next
  • Last